These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 6286277

  • 1. [Proserotoninergic agents and depression (author's transl)].
    Uzan A.
    Encephale; 1982; 8(2):273-89. PubMed ID: 6286277
    [Abstract] [Full Text] [Related]

  • 2. The antidepressant effects of 5-HT uptake inhibitors.
    Aberg-Wistedt A.
    Br J Psychiatry Suppl; 1989 Dec; (8):32-40. PubMed ID: 2692638
    [Abstract] [Full Text] [Related]

  • 3. [Biochemical characterization and study by quantitative autoradiography of the binding sites of indalpine, a 5-HT uptake inhibitor, in cat brain].
    Benavides J, Malgouris C, Daniel M, Savaki H, Uzan A, Gueremy C, Le Fur G.
    Encephale; 1985 Dec; 11(6):247-54. PubMed ID: 3830692
    [Abstract] [Full Text] [Related]

  • 4. [Biochemical aspects of depression (author's transl)].
    Duchemin AM.
    Sem Hop; 1985 Dec; 57(15-16):745-50. PubMed ID: 6269184
    [Abstract] [Full Text] [Related]

  • 5. [Development of biological psychiatric depression research (author's transl)].
    Matussek N.
    MMW Munch Med Wochenschr; 1981 May 08; 123(19):793-4. PubMed ID: 6262640
    [Abstract] [Full Text] [Related]

  • 6. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M, David DJ, Jolliet P, Gardier A.
    Therapie; 2002 May 08; 57(4):385-96. PubMed ID: 12422559
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Brain 5-HT uptake sites, labelled with [3H]-paroxetine, in post-mortem samples from depressed suicide victims.
    Lawrence KM, De Paermentier F, Cheetham SC, Crompton MR, Katona CL, Horton RW.
    Br J Pharmacol; 1989 Dec 08; 98 Suppl():812P. PubMed ID: 2532944
    [No Abstract] [Full Text] [Related]

  • 9. Therapeutic effects of serotonin uptake inhibitors in depression.
    Asberg M, Eriksson B, Mårtensson B, Träskman-Bendz L, Wägner A.
    J Clin Psychiatry; 1986 Apr 08; 47 Suppl():23-35. PubMed ID: 2937776
    [Abstract] [Full Text] [Related]

  • 10. Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant.
    Aberg A.
    Acta Psychiatr Scand Suppl; 1981 Apr 08; 290():244-55. PubMed ID: 6452794
    [Abstract] [Full Text] [Related]

  • 11. CGP 6085 A, a new, specific, inhibitor of serotonin uptake: neurochemical characterization and comparison with other serotonin uptake blockers.
    Waldmeier PC, Baumann PA, Maítre L.
    J Pharmacol Exp Ther; 1979 Oct 08; 211(1):42-9. PubMed ID: 490325
    [No Abstract] [Full Text] [Related]

  • 12. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
    Kuroki T, Nagao N, Nakahara T.
    Prog Brain Res; 2008 Oct 08; 172():199-212. PubMed ID: 18772034
    [Abstract] [Full Text] [Related]

  • 13. 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs?
    Stahl S.
    Psychopharmacol Bull; 1994 Oct 08; 30(1):39-43. PubMed ID: 7972628
    [Abstract] [Full Text] [Related]

  • 14. The clinical utility of pharmacological agents that act at serotonin receptors.
    Peroutka SJ, Sleight AJ, McCarthy BG, Pierce PA, Schmidt AW, Hekmatpanah CR.
    J Neuropsychiatry Clin Neurosci; 1989 Oct 08; 1(3):253-62. PubMed ID: 2562495
    [Abstract] [Full Text] [Related]

  • 15. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G.
    J Pharmacol Exp Ther; 1998 Sep 08; 286(3):1341-55. PubMed ID: 9732398
    [Abstract] [Full Text] [Related]

  • 16. A silver bullet for the treatment of depression?
    Duman RS.
    Neuron; 2007 Sep 06; 55(5):679-81. PubMed ID: 17785173
    [Abstract] [Full Text] [Related]

  • 17. [Can a serotonin uptake agonist be an authentic antidepressant? Results of a multicenter, multinational therapeutic trial].
    Kamoun A, Delalleau B, Ozun M.
    Encephale; 1994 Sep 06; 20(5):521-5. PubMed ID: 7828515
    [Abstract] [Full Text] [Related]

  • 18. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.
    Andrews AM, Murphy DL.
    J Pharmacol Exp Ther; 1993 Dec 06; 267(3):1432-9. PubMed ID: 8263805
    [Abstract] [Full Text] [Related]

  • 19. [Behavior of 5-HT receptors during long-term antidepressant treatment and at discontinuation].
    Fillion G.
    Encephale; 1995 Feb 06; 21 Spec No 1():3-6. PubMed ID: 7729352
    [No Abstract] [Full Text] [Related]

  • 20. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
    de Lago E, Ortega-Gutiérrez S, Ramos JA, López Rodríguez ML, Fernández-Ruiz J.
    Life Sci; 2007 Feb 13; 80(10):979-88. PubMed ID: 17173937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.